Table 1.
The relationship of tRF-19-3L7L73JD levels (∆Ct) in plasma with clinicopathological factors of patients with gastric cancer.
| Factors | Samples (%) | Low (%) | High (%) | P |
|---|---|---|---|---|
| Cases | 89 (100) | 45 (50.6) | 44 (49.4) | |
| Gender | ||||
| Male | 60 (67.4) | 31 (68.9) | 29 (65.9) | 0.7643 |
| Female | 29 (32.6) | 14 (31.1) | 15 (34.1) | |
| Age (y) | ||||
| ≥60 | 69 (77.5) | 34 (75.6) | 35 (79.5) | 0.6521 |
| <60 | 20 (22.5) | 11 (24.4) | 9 (20.5) | |
| CEA | ||||
| Positive | 14 (15.7) | 8 (17.8) | 6 (13.6) | 0.5916 |
| Negative | 75 (84.3) | 37 (82.2) | 38 (86.4) | |
| CA19-9 | ||||
| Positive | 15 (16.9) | 10 (22.2) | 5 (11.4) | 0.1713 |
| Negative | 74 (83.1) | 35 (77.8) | 39 (88.6) | |
| Differentiation | ||||
| Well | 58 (65.2) | 26 (57.8) | 32 (72.7) | 0.1389 |
| Moderate-Poor | 31 (34.8) | 19 (42.2) | 12 (27.3) | |
| Tumor-size (cm) | ||||
| ≤5 | 65 (73.0) | 27 (60.0) | 38 (86.4) | 0.0051 |
| >5 | 24 (27.0) | 18 (40.0) | 6 (13.6) | |
| TNM stage | ||||
| 0 & I | 33 (37.1) | 15 (33.3) | 18 (40.9) | 0.4028 |
| II | 18 (20.2) | 10 (22.2) | 8 (18.2) | |
| III | 36 (40.4) | 20 (44.4) | 16 (36.4) | |
| IV | 2 (2.2) | 0 (0.0) | 2 (4.5) | |
| Invasion | ||||
| Tis | 3 (3.4) | 2 (4.4) | 1 (2.3) | 0.6822 |
| T1 | 25 (28.1) | 12 (26.7) | 13 (29.5) | |
| T2 & T3 | 11 (12.4) | 4 (8.9) | 7 (15.9) | |
| T4 | 50 (56.2) | 27 (60.0) | 23 (52.3) | |
| Lymphatic metastasis | ||||
| N0 | 39 (43.8) | 20 (44.4) | 19 (43.2) | 0.0739 |
| N1 | 22 (24.7) | 7 (15.6) | 15 (34.1) | |
| N2 & N3 | 28 (31.5) | 18 (40.0) | 10 (22.7) | |
| Distal metastasis | ||||
| M0 | 87 (97.8) | 45 (100.0) | 42 (95.5) | 0.1480 |
| M1 | 2 (2.2) | 0 (0.0) | 2 (4.5) |